Cargando…
USP35 promotes hepatocellular carcinoma progression by protecting PKM2 from ubiquitination-mediated degradation
Hepatocellular carcinoma (HCC) is the most frequently diagnosed primary liver cancer with a high mortality rate and imposes a huge burden on patients and society. Recently, ubiquitin-specific protease 35 (USP35) was found to be involved in cell proliferation and mitosis, but its role in HCC remains...
Autores principales: | Lv, Tao, Zhang, Bo, Jiang, Chenghao, Zeng, Qiwen, Yang, Jiayin, Zhou, Yongjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552738/ https://www.ncbi.nlm.nih.gov/pubmed/37594129 http://dx.doi.org/10.3892/ijo.2023.5561 |
Ejemplares similares
-
Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation
por: Wu, Linhui, et al.
Publicado: (2022) -
USP8 modulates ubiquitination of LRIG1 for Met degradation
por: Oh, Young Mi, et al.
Publicado: (2014) -
Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma
por: Chen, Zhiao, et al.
Publicado: (2014) -
USP30 protects against oxygen-glucose deprivation/reperfusion induced mitochondrial fragmentation and ubiquitination and degradation of MFN2
por: Chen, Chunli, et al.
Publicado: (2021) -
TRIM35 ubiquitination regulates the expression of PKM2 tetramer and dimer and affects the malignant behaviour of breast cancer by regulating the Warburg effect
por: Wu, Hao, et al.
Publicado: (2022)